Result Summary for 207499/040
| Protocol ID: | 207499/040 |
| Clinical Study ID: | 207499/040 |
| Official Title: | A Multicentre, Open-label Extension Study to Evaluate the Safety, Tolerability and Efficacy of Oral SB-207499 (15 mg twice daily) in Patients with Chronic Obstructive Pulmonary Disease (COPD). |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | cilomilast |
| Trade/Product Name: | ariflo |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: | Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.

Click
here to download result summary.